Death rate in Bangladesh student protests rises to over 120


(MENAFN) As the curfew in Bangladesh eases gradually, the death toll from anti-job quota student protests in the capital Dhaka has risen, with more protesters succumbing to bullet wounds. The total number of fatalities now stands at 211, according to officials and local media reports. Despite attempts to contact hospital authorities, including Dhaka Medical College Hospital (DMCH) and its dedicated police post for information, no updates were provided. However, local English newspaper New Age reported that two more critically injured individuals died early Saturday while receiving treatment at DMCH, bringing the death toll to at least 211 nationwide due to the recent violence during student protests.

The protests have also resulted in over 1,600 people being treated for injuries at the hospital, as reported by New Age. In response to the ongoing unrest, the government announced the continuation of the military curfew for the eighth consecutive day, stating it would remain in place until the situation improves. The curfew is lifted for a nine-hour period starting from 8:00 AM each day. Home Minister Asaduzzaman Khan stated late Friday night that law enforcement agencies were continuously assessing the situation to determine when the curfew could be fully withdrawn.

Despite no reports of untoward incidents on Saturday, soldiers were still patrolling the capital, Dhaka. Offices and industries have started reopening since Wednesday, signaling a slow return to normalcy. Prime Minister Sheikh Hasina visited several hospitals in Dhaka on Saturday to check on the injured and later inspected damaged government establishments that had been attacked during the protests. The government’s actions indicate a continued effort to stabilize the situation and address the aftermath of the violent clashes.

MENAFN28072024000045015839ID1108490605


MENAFN

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Newsletter